Principia Biopharma Inc., a late-stage biopharmaceutical company, focuses on developing novel therapies for immune-mediated diseases. The company developing rilzabrutinib, an inhibitor that is in ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

Sanofi is to buy Principia Biopharma for up to $3.68 billion, adding a potential multiple sclerosis drug to its pipeline. The French pharma said it will pay $100 per share in cash for San ...

Sanofi has not had the success it was hoping for with its oral BTK inhibitors, acquired as part of its $3.7 billion buyout of Principia Biopharma, but can now point to a win for rilzabrutinib in ...

* Per the 2022-2023 final release data in IPEDS ‡ The median salary for workers with 10 or more years of experience per Payscale. Principia College is a private liberal arts college in Elsah, Ill.

FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety ...

SILICON VALLEY, CA - May 14, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system ...

Explore Arbutus Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABUS. Alnylam Pharmaceuticals has conceded that Moderna's products do not ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein ...